Recently, the research team led by Professor Zhang Zhongtao and Professor Yao Hongwei from the General Surgery Center at ...
Standard treatment for resectable endometrial cancer often consists of surgery ... Prior studies showed immune checkpoint blockade in the neoadjuvant setting conferred favorable outcomes for ...
NEW YORK - A Ludwig Cancer Research study has identified a key barrier to the efficacy of a promising combination of ...
Durable complete response (CR) in a MCC patient treated with 15 mg/kg solnerstotug + cemiplimab. Patient continues on ...
9d
The therapy, a fully human monoclonal antibody, targets a newly identified immune checkpoint protein that could enhance ...
SPP1+ Macrophages Identified as Key Drivers and Therapeutic Targets In Colorectal Cancer Progression
Colorectal cancer (CRC) is the third most common malignancy and the second leading cause of cancer-related deaths worldwide.
While PD-1/PD-L1 blockade has demonstrated remarkable clinical successes, recent studies suggest that its novel target has a ...
The therapy, a fully human monoclonal antibody, targets a newly identified immune checkpoint protein that could enhance ...
Karnataka: Shilpa Biologicals Pvt Ltd., a fully owned subsidiary of Shilpa Medicare Limited has signed an exclusive ...
Hepatocellular carcinoma (HCC), the third leading cause of cancer-related deaths worldwide, remains one of the most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback